Emcure Pharmaceuticals Share Price
1927.60+72.90 (+3.93%)
+40.56% past 1 Year
News
Emcure Pharmaceuticals to host analyst and investor meeting on September 4
Equity
EMCURE
Emcure Pharma gets Buy call, target raised to Rs 2,300
Equity
EMCURE
Jefferies maintains buy on Emcure Pharma, raises FY27 to FY29 earnings outlook
Equity
EMCURE
Emcure Pharma Q1 EBITDA rises with improved operating margin performance
Equity
EMCURE
Emcure Pharma reports Q1 revenue growth to Rs 2,600 crores
Equity
EMCURE
Emcure Pharma Q1 profit rises sharply on strong year-on-year growth
Equity
EMCURE
Emcure Pharma gets ICMR anti-HPV technology licence, expanding oncology pipeline
Equity
EMCURE
CDSCO clears Wegovy for fatty liver disease, boosting Emcure’s GLP-1 portfolio
Equity
EMCURE
Emcure Pharmaceuticals schedules Q1 earnings conference call for investor interaction
Equity
EMCURE
Emcure Pharmaceuticals to review first quarter results on August 6
Equity
EMCURE
Emcure Pharma secures full control of Gennova via remaining 12.05% stake buy
Equity
EMCURE
Emcure Pharma to fully acquire Gennova Biopharmaceuticals via remaining stake purchase
Equity
EMCURE
Emcure Pharma arm to acquire remaining stake in Canada’s Mantra Pharma
Equity
EMCURE
Jefferies raises Emcure Pharmaceuticals target on growth outlook
Equity
EMCURE
Emcure Pharma sees NSE block trade worth Rs 26.65 crores in equity
Equity
EMCURE
Emcure Pharmaceuticals informs about investor presentation
Equity
EMCURE
Kotak Mahindra Mutual Fund buys stake worth Rs 612 crore in Emcure Pharmaceuticals
Equity
EMCURE
Block deal in Emcure Pharma shares on NSE pre-open session
Equity
EMCURE
USFDA concludes cGMP inspection at Emcure Pharmaceuticals’ Gujarat facility
Equity
EMCURE
Emcure Pharmaceuticals informs about ESG rating
Equity
EMCURE